|
RCC with Sarcomatoid Differentiation |
04/26/2024 - 8:00am to 9:00am EDT |
|
The A-Team Against Relapsed/Refractory Myeloma: Community Strategies for Enhancing Outcomes With Potent CD38 Antibody Platforms |
05/03/2024 - 8:00am to 9:00am EDT |
|
CDK 4/6 Inhibitors in Metastatic Breast Cancer |
05/10/2024 - 8:00am to 9:00am EDT |
|
Response Matters: Practice Changing Strategies in Community Care Settings for Patients with CLL/SLL/MCL |
05/17/2024 - 8:00am to 9:00am EDT |
|
Case of Relapsed DLBCL |
05/24/2024 - 8:00am to 9:00am EDT |
|
A Case of Pure Red Cells Aplasia |
06/07/2024 - 8:00am to 9:00am EDT |
|
Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer |
06/14/2024 - 8:00am to 9:00am EDT |
|
Metastatic Her2/Neu Breast Cancer |
06/21/2024 - 8:00am to 9:00am EDT |
|
Genetic Testing for Inherited Cancer Risk |
06/28/2024 - 8:00am to 9:00am EDT |
|
Changing Paradigm: Evaluating the Use of FLT3 Inhibitors in Patients with AML |
07/12/2024 - 8:00am to 9:00am EDT |
Facebook
X
LinkedIn
Forward